Aim ABO blood group genotypes are established as a genetic factor in pathophysiology of various diseases, such as cardiovascular disorders, cancers, infectious diseases and there is rising evidence of their involvement in other conditions. The aim of this study was to determine if ventilatory changes of lung function in asthma, measured by biomarkers/parameters, are connected to certain ABO blood group genotypes in Croatia. Methods A case-control study included 149 patients with asthma and 153 healthy individuals (blood donors). ABO genotyping on five main alleles was performed using PCR-SSP method. All patients had spirometry performed and severity of asthma was estimated. Clinical parameters of spirometry (FEV 1 , FEV/FVC, PEF), biomarkers FeNO, IgE and pO2 were measured. The χ 2 test, Fisher's test, Kruskal-Wallis test and Spearman's correlation coefficients with p˂0.05 were used as statistically significant. Results There was no determined statistically significant difference in both ABO genotypes and phenotypes between patient and control groups. Comparison of the lung function in different ABO phenotypes in asthmatic patients also did not show any statistically significant differences in FEV1 values, FEV/FVC ratio or PEF. Statistically significant differences in oxygenation between different ABO blood types have not been noticed (p=0.326). Differences in quantitative values of biomarkers (FeNO and IgE) between different ABO blood phenotypes in patients with asthma were not significant, except for IgE that had marginal values (p=0.074). Conclusion No correlation was found between certain ABO blood group genotypes and parameters/biomarkers of ventilatory dysfunction in patients with allergic and nonallergic asthma.
Aymard J. Karl Landsteiner (1868-1943) and the discovery of blood groups. Transfus Clin Biol. 2012. p. 244–8.
2.
Yamamoto F. Molecular genetics of the ABO histoblood group system. Vox Sang. 1995. p. 1.
3.
Seltsam A, Hallensleben, Kollomann A, Blasczyk R. The nature of diversity and diversification at the ABO locus. Blood. 2003. p. 3035–42.
4.
Garratty G. Relationship of blood groups to disease: do blood group antigens have a biological role? Revista. Medica del Instituto Mexicano Seguro Social. 2005. p. 113–21.
5.
Liumbruno G, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013. p. 491–9.
6.
Franchini M, Liumbruno G, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016. p. 434–40.
7.
Rummel S, Ellsworth R. The role of the histoblood ABO group in cancer. Future Sci OA. 2016. p. 107.
8.
Hakomori S. Antigen structure and a genetic basis of histo blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta. 1999. p. 247–66.
9.
Jukic I, Bingulac-Popovic J, Dogic V, Babic I, Culej J, Tomicic M, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J. 2009. p. 550–8.
10.
Franchini M, Marano G, Vaglio S, Catalano L, Pupella S, Liumbruno G. The Role of ABO Blood Type in Thrombosis Scoring Systems. 2017. p. 525–9.
11.
Falsarella N, Ferreira A, Nakashima F, De Mattos Cde C, De Mattos L. Evidence of an association between the O blood group and allergic rhinitis. Rev Bras Hematol Hemoter. 2011. p. 444–8.
12.
Carpeggiani C. Allergic rhinitis and association with the O blood group. Rev Bras Hematol Hemoter. 2011. p. 406–7.
13.
Kauffmann F, Frette C, Pham Q, Nafissi S, Bertrand J, Oriol R. Associations of blood group-related antigens to FEV1, wheezing, and asthma. Am J Respir Crit Care Med. 1996. p. 76–82.
14.
Bijanzadeh M, Ramachandra N, Mahesh P, Savitha M, Manjunath B, Jayaraj B. Lack of association between asthma and ABO blood group. Lung. 2009. p. 389–92.
15.
Ganguly S, Sarkar P, Chatterjee D, Bandyopadhyay A. Association of ABO blood group polymorphism and tuberculosis: A study on Bengalee Hindu caste population. Indian J Tuberc. 2016. p. 242–4.
16.
Chrysanthakopoulos N, Dareioti N. ABO blood group and the risk of lung cancer in Greek adults: a case -control study. Exp Oncol. 2018. p. 249–50.
17.
Chang C. Current Clinical Practice: Bronchial Asthma: a Guide for Practical Understanding and Treatment. Humana Press Inc; 2006. p. 65–111.
18.
Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007. p. 758–66.
19.
The global burden of asthma report. Global initiative for asthma (GINA). 9AD.
20.
Van Eerdewegh P, Little R, Dupuis J, Mastro D, Falls R, Simon K, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 2002. p. 426–30.
21.
Hakonarson H, Halapi E. Genetic analyses in asthma: current concepts and future directions. Am J Pharmacogenomics. 2002. p. 155–66.
22.
Bijanzadeh M, Mahesh P, Ramachandra N. An understanding of the genetic basis of asthma. Indian J Med Res. 2011. p. 149–61.
23.
Pevec B, Pevec R, M, Markovic S, Batista A, Rijavec I, et al. House dust mite-specific immunotherapy alters the basal expression of T regulatory and FcERI pathway genes. Int Arch Allergy Immunol. 2012. p. 287–96.
24.
Ciprandi G, Gallo F. The impact of gender on asthma in the daily clinical practice. Postgrad Med. 2018. p. 271–3.
25.
Gassner C, Schmard A, Nussbaumer W, Schönitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood. 1996. p. 1852–6.
26.
De La Vega A, Gómez C, Bacallao G. Genetic polymorphism of ABO and Rh system in relation to bronchial asthma: preliminary report. Allergol Immunopathol (Madr). 1976. p. 305–10.
27.
Alo M, Eze U, Yaro A, Jubril S, B. Nwanoke NN. Relationship between ABO and Rhesus blood groups and susceptibility to asthma within Sokoto metropolis. Int J Immunol. 2015. p. 37–41.
28.
Brachtel R, Walter H, Beck W, Hilling M. Associations between atopic diseases and the polymorphic systems ABO, Kidd, Inv and red cell acid phosphatase. Hum Genet. 1979. p. 337–48.
29.
Topno N, Narvey V, Jain A. The correlation of allergic rhinitis with ABO phenotype. Indian J Otolaryngol Head Neck Surg. 2019. p. 1827–31.
30.
Ronchetti F, Villa M, Ronchetti R, Bonci E, Latini L, Pascone R, et al. ABO/Secretor genetic complex and susceptibility to asthma in childhood. Eur Respir J. 2001. p. 1236–8.
31.
Patella V, Bocchino M, Steinhilber G. Asthma is associated with increased susceptibility to infection. Minerva Med. 2015. p. 1–7.
32.
Bottini N, Ronchetti F, Bottini G, F. Cooperative effect of adenosine deaminase and ABO-secretor genetic complex on susceptibility to childhood asthma. Eur Respir J. 2002. p. 1613–5.
33.
Quinzii C, Belpinati F, Pignatti P. Predictive Genetic Testing -New Possibilities in Determination of Risk of Complex Diseases. Croat Med J. 2001. p. 458–62.
34.
Sanz-Lozano C, García-Solaesa V, Davila I, Isidoro-García M. Applications of molecular genetics to the study of asthma. Methods Mol Biol. 2016. p. 1–13.
35.
Chen Y, Chen J, Lin T, Huang T, Wang S, Lee M, et al. ABO/secretor genetic complex is associated with the susceptibility of childhood asthma in Taiwan. Clin Exp Allergy. 2005. p. 926–32.
36.
Uwaezuoke S, Eze J, Ayuk A, Ndu I. ABO histo-blood group and risk of respiratory atopy in children: a review of published evidence. Pediatric Health Med Ther. 2018. p. 73–9.
37.
Dahalan N, Din T, S, Smb M. Association of ABO blood groups with allergic diseases: a scoping review. BMJ Open. 2020. p. 29559.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
